Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Reset all filters
01 6Evonik
02 4Actylis
03 22BASF
04 2Gangwal Chemicals
05 1Microlex e.U
06 4Roquette
07 1The Dow Chemical Company
Reset all filters
Reset all filters
Application : Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® L 100 (powder), a delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.
Ingredient(s) : METHACRYLIC ACID COPOLYMER TYPE A
Category : Controlled & Modified Release, Solubilizers
Brand : EUDRAGIT® L 100
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Application : Solubilizers
Excipient Details : EUDRAGIT® L 12,5 (organic solution), a delayed release polymer is used to increase solubility of poorly soluble products such as tablets and capsules.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer
Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer
Category : Solubilizers
Brand : EUDRAGIT® L 12,5
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Application : Solubilizers
Excipient Details : EUDRAGIT® S 12,5 (Organic solution) a delayed release polymer, used to increase solubility of poorly soluble drugs such as tablets and capsules.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer
Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer
Category : Solubilizers
Brand : EUDRAGIT® S 12,5
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral